Valor II: The Valiant Thoracic Stent Graft System Clinical Study

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

October 31, 2014

Conditions
Thoracic Aortic Aneurysm
Interventions
DEVICE

Valiant Thoracic Stent Graft System

Surgical procedure in which a device is implanted inside the aorta, isolating the diseased area (aneurysm).

Trial Locations (26)

10016

New York University Medical Center, New York

10029

Mount Sinai School of Medicine, New York

12208

Albany Medical Center, Albany

15232

Shadyside Hospital - University of Pittsburgh Medical Center, Pittsburgh

19104

University of Pennsylvania, Philadelphia

21218

Union Memorial, Baltimore

22042

Inova Fairfax Hospital, Falls Church

22908

University of Virginia, Charlottesville

27599

University of North Carolina, Chapel Hill

30322

Emory University Hospital, Atlanta

32610

University of Florida, Gainesville

33606

University of South Florida, Tampa

35294

University of Alabama at Birmingham, Birmingham

38120

Baptist Memorial Hospital, Memphis

44195

Cleveland Clinic Foundation, Cleveland

48073

William Beaumont Hospital, Royal Oak

55441

Minneapolis Vascular Physicians, Plymouth

60153

Loyola University Medical Center, Maywood

63110

Washington University School of Medicine, St Louis

77030

Baylor College of Medicine, Houston

St. Luke's Episcopal Hospital - Houston, Houston

90033

University of Southern California - Healthcare Consultation Center, Los Angeles

90502

Los Angeles Biomedical Research Institute @ Harbor-UCLA Medical Center, Torrance

06106

Hartford Hospital, Hartford

02114

Massachusetts General Hospital, Boston

07960

Advance Vascular Associates (Morristown Memorial Hospital), Morristown

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY

NCT00413231 - Valor II: The Valiant Thoracic Stent Graft System Clinical Study | Biotech Hunter | Biotech Hunter